A systematic review and meta-regression analysis of lung cancer risk and inorganic arsenic in drinkingwater

International Journal of Environmental Research and Public Health

Volumn 12, Issue 12, 2015, Pages 15498-15515

  Lamm, Steven H ^a,b,c   Ferdosi, Hamid ^a,d   Dissen, Elisabeth K ^a   Li, Ji ^e   Ahn, Jaeil ^c  

^a Center in Epidemiology and Environmental Health   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGE WASHINGTON UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arsenic; Dose response; Drinking water; Lung cancer; Risk analysis

Indexed keywords

ARSENIC; DRINKING WATER; WATER POLLUTANT;

ARSENIC; CANCER; DOSE-RESPONSE RELATIONSHIP; DRINKING WATER; EPIDEMIOLOGY; HEALTH IMPACT; HEALTH RISK; REGRESSION ANALYSIS; RESPIRATORY DISEASE; RISK ASSESSMENT;

CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CHILE; COHORT ANALYSIS; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; LIMIT OF DETECTION; LUNG CANCER; LUNG CARCINOGENESIS; MALE; META ANALYSIS; REGRESSION ANALYSIS; REVIEW; RISK ASSESSMENT; SMOKING; SYSTEMATIC REVIEW; TAIWAN; UNITED STATES; WATER POLLUTION; CHEMICALLY INDUCED; CHEMISTRY; LUNG TUMOR; RISK FACTOR; STATISTICAL MODEL; TOXICITY; WATER POLLUTANT;

ARSENIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING WATER; HUMANS; LUNG NEOPLASMS; MODELS, STATISTICAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTORS; WATER POLLUTANTS, CHEMICAL;

EID: 84949293706     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph121214990     Document Type: Review

References (52)

1. World Health Organization. Exposure to Arsenic—A Major Public Health Concern. Available online: www.who.int_ipcs_features_arsenic (accessed on 17 November 2014).
2. IARC. IARC monographs on the evaluation of carcinogenic risk to humans. In A Review of Human Carcinogens: Arsenic, Metals Fibers and Dusts; International Agency for Research on Cancer (IARC): Lyon, France, 2012.
3. U.S. Environmental Protection Agency (USEPA). Integrated Risk Information System (IRIS) on Arsenic; National Center for Environmental Assessment, Office of Research and Development: Washington, DC, USA, 1998.
4. Chen, C.J.; Chuang, Y.C.; Lin, T.M.; Wu, H.Y. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: High arsenic artesian well water and cancers. Cancer Res. 1985, 45, 5895–5899. [PubMed]
5. Wu, M.M.; Kuo, T.L.; Hwang, Y.H.; Chen, C.J. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am. J. Epidemiol. 1989, 130, 1123–1132.
6. Chiou, H.Y.; Chiou, S.T.; Hsu, Y.H.; Chou, Y.L.; Tseng, C.H.; Wei, M.L.; Chen, C.J. Incidence of transitional cell carcinoma and arsenic in drinking water: A follow up study of 8102 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 2001, 153, 411–418. [CrossRef]
7. Rivara, M.I.; Cebrian, M.; Corey, G.; Hernandez, M.; Romieu, I. Cancer risk in an arsenic-contaminated area of Chile. Toxicol. Ind. Health 1997, 13, 321–338. [CrossRef] [PubMed]
8. Ferreccio, C.; Gonzalez, P.C.; Milosavjlevic, S.V.; Marshal, G.G.; Sancha, A.M. Lung cancer and arsenic exposure in drinking water: A case control study in northern Chile. Cad. Saude Publica 1998, 14, 193–198. [CrossRef] [PubMed]
9. Smith, A.H.; Goycolea, M.; Haque, R.; Biggs, M.L. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 1998, 147, 660–669. [CrossRef]
10. Hopenhayn-Rich, C.; Biggs, M.L.; Fuchs, A.; Bergoglio, R.; Tello, E.E.; Nicolli, H.; Smith, A.H. Bladder cancer mortality associated with arsenic in drinking water in Argentina. Epidemiology 1996, 7, 117–124. [CrossRef] [PubMed]
11. Hopenhayn-Rich, C.; Biggs, M.L.; Smith, A.H. Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, Argentina. Int. J. Epidemiol. 1998, 27, 561–569. [CrossRef]
12. Mostafa, M.G.; McDonald, J.C.; Cherry, N.M. Lung cancer and exposure to arsenic in rural Bangladesh. Occup. Environ. Med. 2008, 65, 765–768. [CrossRef] [PubMed]
13. Tsuda, T.; Babazono, A.; Yamamoto, E.; Kurumatani, N.; Mino, Y.; Ogawa, T.; Aoyama, H. Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am. J. Epidemiol. 1995, 141, 198–209.
14. Celik, I.; Gallicchio, L.; Boyd, K.; Lam, T.K.; Matanoski, G.; Tao, X.G.; Alberg, A.J. Arsenic in drinking water and lung cancer: A systematic review. Environ. Res. 2008, 108, 48–55. [CrossRef] [PubMed]
15. Gibb, H.; Haver, C.; Gaylor, D.; Ramasamy, S.; Lee, J.S.; Lobdell, D.; Sams, R. Utility of recent studies to assess the national research council 2001 estimates of cancer risk from ingested arsenic. Environ. Health Perspect. 2011, 119, 284–290. [CrossRef] [PubMed]
16. Cohen, S.; Arnold, L.; Beck, B.; Lewis, A.; Eldan, M. Evaluation of the carcinogenicity of inorganic arsenic. Crit. Rev. Toxicol. 2013, 43, 711–752. [CrossRef] [PubMed]
17. Lamm, S.H.; Robbins, S.A.; Zhou, C.; Lu, J.; Chen, R.; Feinleib, M. Bladder/Lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels—An exploration of the dose-response Poisson analysis. Regul. Toxicol. Pharmacol. 2013, 65, 147–56. [PubMed]
18. Schoen, A.; Beck, B.; Sharma, R.; Dube, E. Arsenic toxicity at low doses: Epidemiological and mode of action considerations. Toxicol. Appl. Pharmacol. 2004, 198, 253–267. [CrossRef] [PubMed]
19. Snow, E.T.; Sykora, P.; Durham, T.R.; Kelin, C.B. Arsenic, mode of action at biologically plausible low doses: What are the implications for low dose cancer risk? Toxicol. Appl. Pharmacol. 2005, 207, 557–564. [CrossRef] [PubMed]
20. Smith, A.H.; Ercumen, A.; Yan, Y.; Steinmaus, C.M. Increased lung cancer risks are similar whether arsenic is ingested or inhaled. J. Expo. Sci. Environ. Epidemiol. 2009, 19, 343–348. [CrossRef] [PubMed]
21. Bogen, K.T.; Chen, C.L.; Tsuji, J.S. Significant nonlinearity of lung cancer risk in relation to arsenic in drinking water in northeastern Taiwan. Toxicol. Sci. 2014, 138, 62.
22. Microsoft Excel; Microsoft: Redmond,Washington, USA, 2010.
23. Stata Statistical Software: Release 13.2; Stata Corp. Lp.: College Station, TX, USA, 2013.
24. Knapp, G.; Hartung, J. Improved tests for a random-effects meta-regression with a single covariate. Stat. Med. 2003, 22, 2693–2710. [CrossRef] [PubMed]
25. Harbord, R; Higgins, J. Meta-regression in Stata. Stata J. 2008, 8, 493–519.
26. Putila, J.J.; Guo, N.L. Association of arsenic exposure with lung cancer incidence rates in the United States. PLoS ONE 2011, 6, 1–7. [CrossRef] [PubMed]
27. Heck, J.; Andrew, A.; Onega, T.; Rigas, J.; Jackson, B.; Karagas, M.; Duell, E. Lung cancer in a U.S. population with low to moderate arsenic exposure. Environ. Health Perspect. 2009, 117, 1718–1723. [PubMed]
28. Garcia-Esquinas, E.; Pollan, M.; Umasn, J.G.; Francesconi, K.A.; Goessler, W.; Guallar, E.; Navas-Acien, A. Arsenic exposure and cancer mortality in a U.S. based prospective cohort: The strong heart study. Cancer Epidemiol. Biomarker Prev. 2013, 22, 1944–1953. [CrossRef] [PubMed]
29. Erraguntla, N.K.; Sielken, R.J.; Valdez-Flores, C.; Grant, R.L. An updated inhalation unit risk factor for arsenic and inorganic arsenic compounds based on a combined analysis of epidemiology studies. Regul. Toxicol. Pharmacol. 2012, 64, 329–341. [CrossRef] [PubMed]
30. Lewis, D.R.; Southwick, J.W.; Quellet-Hellstrom, R.; Rench, J.; Calderon, R.L. Drinking water arsenic in Utah: A cohort mortality study. Environ. Health Perspect. 1999, 170, 359–365. [CrossRef]
31. Guo, H. Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Cause. Control 2004, 15, 171–177. [CrossRef] [PubMed]
32. Chung, Y.; Liaw, Y.; Hwant, B.; Cheng, Y.; Lin, M.; Kuo, Y.; Guo, H. Arsenic in drinking and lung cancer mortality in Taiwan. J. Asian Earth Sci. 2013, 77, 327–331. [CrossRef]
33. Baastrup, R.; Sorensen, M.; Balstrom, T.; Frederiksen, K.; Larsen, C.; Tjonneland, A.; Raachou-Nielsen, O. Arsenic in drinking water and risk for cancer in Denmark. Environ. Health Perspect. 2006, 116, 231–237. [CrossRef] [PubMed]
34. Buchet, J.P.; Lison, D. Mortality by cancer in groups of the Belgian population with a moderately increased intake of arsenic. Int. Arch. Occup. Environ. Health 1998, 71, 125–130. [CrossRef]
35. Meliker, J.R.; Wahl, R. L.; Cameron, L.L.; Nriagu, J.O. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: A standardized mortality ration analysis. Environ. Health 2007, 6, 4–11. [CrossRef] [PubMed]
36. Han, Y.; Weissfeld, J.L.; Davis, D.L.; Talbott, E.O. Arsenic levels in ground water and cancer incidence in Idaho: An ecologic study. Int. Arch. Occup. Environ. Health 2009, 82, 843–849. [CrossRef] [PubMed]
37. Steinmaus, C.M.; Ferreccio, C.; Romo, J.A.; Yuan, Y.; Cortes, S.; Marshall, G.; Smith, A.H. Drinking water arsenic in northern Chile: High cancer risks 40 years after exposure cessation. Cancer Epidemiol. Biomarker Prev. 2013, 22, 623–630. [CrossRef] [PubMed]
38. Ferreccio, C.; Sancha, A.M. Arsenic exposure and its impact on health in Chile. J. Health Popul. Nutr. 2006, 24, 164–175. [PubMed]
39. Ferreccio, C.; Yuan, Y.; Calle, J.; Benitez, H.; Parra, R.L.; Acevedo, J.; Steinmaus, C. Arsenic, tobacco smoke, and occupation: Association of multiple agents with lung and bladder cancer. Epidemiology 2013, 24, 898–905. [CrossRef] [PubMed]
40. Morales, K.H.; Ryan, L.; Kuo, T.L.; Wu, M.; Chen, C. Risk of internal cancers from arsenic in drinking water. Environ. Health Perspect. 2000, 108, 655–661. [CrossRef] [PubMed]
41. Dauphine, D.C.; Smith, A.H.; Yuan, Y.; Balmes, J.R.; Bates, M.N.; Steinmaus, C. Case control study of arsenic in drinking water and lung cancer in California and Nevada. Int. J. Environ. Res. Public Health 2013, 10, 3310–3324. [CrossRef] [PubMed]
42. National Research Council. Critical Aspects of EPA’s IRIS Assessment of Inorganic Arsenic—Interim Report; National Academy Press: Washington, DC, USA, 2013.
43. National Research Council. Arsenic in Drinking Water, 2nd ed.; National Academy Press: Washington, DC, USA, 1999; pp. 308–309.
44. Mink, P.J.; Alexander, D.D.; Barraj, L.M.; Kelsh, M.A.; Tsuji, J.S. Low-level arsenic exposure in drinking water and bladder cancer: A review and meta-analysis. Regul. Toxicol. Pharmacol 2008, 52, 299–310. [CrossRef] [PubMed]
45. Tsuji, J.S.; Alexander, D.D.; Perez, V.; Mink, P.J. Arsenic exposure and bladder cancer: Quantitative assessment of studies in human populations to detect risks at low doses. Toxicology 2014, 317, 17–30. [CrossRef] [PubMed]
46. Abernathy, C.O.; Chappell, W.R.; Meek, M.E.; Gibb, H.; Guo, H.R. Is ingested inorganic arsenic a “threshold” carcinogen? Fund. Appl. Pharmacol. 1996, 29, 168–175. [CrossRef]
47. Goering, P.; Aposhian, H.V.; Mass, M.J.; Cebrian, M.; Beck, B.D.; Waalkes, M.P. The enigma of arsenic carcinogenesis: Role of metabolism. Toxicol. Sci. 1999, 49, 5–14. [CrossRef] [PubMed]
48. Schmeisser, S.; Schmeisser, K.; Weimer, S.; Groth, M.; Priebe, S.; Fazius, E.; Ristow, M. Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension. Aging Cell 2013, 12, 508–517. [CrossRef] [PubMed]
49. U.S. Environmental Protection Agency. Guidelines for Carcinogen Risk Assessment; U.S. Environmental Protection Agency: Washington, DC, USA, 2005; pp. 3–22.
50. Dourson, M.; Hertzberg, R.; Allen, B.; Haber, L.; Parker, A; Kroner, O.; Kohrman, M. Evidence-based dose-response assessment for thyroid tumorignesis from acrylamide. Regul. Toxicol. Pharmacol. 2008, 52, 264–289. [CrossRef] [PubMed]
51. Ferreccio, C.; Gonzalez, C.; Milosavjlevic, V.; Marshall, G.; Sanchez, A.M.; Smith, A.H. Lung cancer and arsenic concentrations in drinking water in Chile. Epidemiology 2000, 11, 673–679. [CrossRef] [PubMed]
52. Chen, C-L.; Chiou, H-Y.; Hsu, L-I.; Hsueh, Y-M.; Wu, M-M.; Chen, C-J. Ingested arsenic, characteristics of well water consumption and risk of different histological types of lung cancer in northeastern Taiwan. Environ. Res. 2010, 110, 455–462. [CrossRef] [PubMed]